Avalo Therapeutics, Inc. (AVTX) announced the immediate appointment of Mittie Doyle as the Chief Medical Officer on Tuesday.
With over 20 years of experience in the pharmaceutical/biotech industry, Mittie Doyle is a research physician with various leadership positions in clinical development.
Mittie transitions to Avalo from Aro Biotherapeutics, where she served as Chief Medical Officer since 2021.
Following Doyle's appointment, Avalo's Board approved granting a non-qualified stock option to her employment agreement, enabling her to purchase 234,000 shares of its common stock.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.